These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15609419)

  • 1. Glucocorticoids and bone mineral content in the childhood nephrotic syndrome.
    Cooper MS; Stewart PM
    N Engl J Med; 2004 Dec; 351(25):2655-7; author reply 2655-7. PubMed ID: 15609419
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucocorticoids and bone mineral content in the childhood nephrotic syndrome.
    Gulati S; Gulati K
    N Engl J Med; 2004 Dec; 351(25):2655-7; author reply 2655-7. PubMed ID: 15602029
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucocorticoids and bone mineral content in the childhood nephrotic syndrome.
    Sugiyama T; Tanaka H; Taguchi T
    N Engl J Med; 2004 Dec; 351(25):2655-7; author reply 2655-7. PubMed ID: 15609420
    [No Abstract]   [Full Text] [Related]  

  • 4. Bare-bones fact--children are not small adults.
    Bachrach LK
    N Engl J Med; 2004 Aug; 351(9):924-6. PubMed ID: 15329431
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
    Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA
    N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
    Polito C; La Manna A; Todisco N; Cimmaruta E; Sessa G; Pirozzi M
    Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria.
    Jonkers IJ; Bruijn JA; Vleming LJ
    Am J Kidney Dis; 2004 Oct; 44(4):773-7. PubMed ID: 15384031
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic value of steroids in the nephrotic syndrome.
    Greifer I
    Transplant Proc; 1975 Mar; 7(1):102-7. PubMed ID: 1118890
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.
    Schijvens AM; Ter Heine R; de Wildt SN; Schreuder MF
    Pediatr Nephrol; 2019 Mar; 34(3):389-403. PubMed ID: 29549463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study.
    Sharawat IK; Dawman L; Kumkhaniya MV; Devpura K; Mehta A
    Trop Doct; 2019 Oct; 49(4):292-298. PubMed ID: 31408410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic Syndrome.
    Freundlich M
    J Pediatr; 2006 Sep; 149(3):383-9. PubMed ID: 16939753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems caused by pharmacologic glucocorticoid treatment of nephrotic syndrome.
    Koskimies O
    Klin Padiatr; 1982; 194(3):166-7. PubMed ID: 6290751
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone.
    Saha MT; Laippala P; Lenko HL
    Acta Paediatr; 1998 May; 87(5):545-8. PubMed ID: 9641737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prednisone on thyroid function in children with nephrotic syndrome.
    Kano K; Ito S; Ichimura T
    Horm Metab Res; 1994 Aug; 26(8):395-6. PubMed ID: 7806139
    [No Abstract]   [Full Text] [Related]  

  • 17. Low bone mineral density in nephrotic children with steroid dependence and/or frequent relapsers.
    Kano K; Yamada Y; Nishikura K; Kojima E; Arisaka O
    Clin Nephrol; 2005 Oct; 64(4):323-4. PubMed ID: 16240907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to gluocorticoid therapy of the nephrotic syndrome].
    Hennighausen H; Osten B; Kröger E
    Z Gesamte Inn Med; 1968 Dec; 23(24):816-9. PubMed ID: 5710622
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up in adolescents and adults with corticoid-sensitive nephrotic syndrome beginning in childhood].
    Esquivel N; Grünberg J; Martínez G
    Bol Med Hosp Infant Mex; 1988 May; 45(5):277-83. PubMed ID: 3408554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thyroid functioning in the nephrosic syndrome. I. Influence of the disease and of prolonged corticosteroid therapy on blood iodoproteins and on basal metabolism].
    Balli F; Tamborino G
    Minerva Pediatr; 1969 Nov; 21(44):2109-10. PubMed ID: 5405654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.